28 Stocks Moving In Monday's Pre-Market Session

Gainers

  • Array BioPharma Inc. ARRY rose 59% to $47.05 in pre-market trading after Pfizer Inc. PFE announced plans to acquire Array BioPharma for $48 per share in cash.
  • Daktronics, Inc DAKT rose 19.6% to $7.50 in pre-market trading.
  • Orgenesis Inc. ORGS rose 18.9% to $5.10 in pre-market trading after the company disclosed that it has been granted FDA Orphan Drug designation for its Autologous Insulin Producing cells in the treatment of Severe hypoglycemia-prone diabetes resulting from total pancreatectomy.
  • Castle Brands Inc ROX rose 17.2% to $0.60 in pre-market trading following Q4 results. Castle Brands posted Q4 earnings of $0.05 per share on sales of $29.89 million.
  • Calithera Biosciences, Inc. CALA rose 15.6% to $6.02 in pre-market trading after reporting 'positive' topline results in randomized Phase 2 ENTRATA study of telaglenastat with everolimus in renal cell carcinoma.
  • Aclaris Therapeutics, Inc. ACRS rose 15.6% to $5.40 in pre-market trading after reporting positive 6-month results from a Phase 2 open-label clinical trial of ATI-502 topical in patients with androgenetic alopecia.
  • Globant S.A. GLOB rose 12.6% to $112.00 in pre-market trading.
  • Riot Blockchain, Inc. RIOT rose 11% to $3.03 in pre-market trading after gaining 5.41% on Friday.
  • Uniqure NV QURE rose 8.9% to $79.00 in pre-market trading following Bloomberg report that the company is exploring options including a potential sale.
  • Antero Midstream Corporation AM gained 8% to $12.50 in pre-market trading after falling 5.24% on Friday.
  • OrganiGram Holdings Inc. OGI shares rose 7.7% to $6.75 in pre-market trading after dropping 7.79% on Friday.
  • Jazz Pharmaceuticals plc JAZZ rose 6.6% to $139.00 in pre-market trading.
  • ReWalk Robotics Ltd. RWLK rose 6.5% to $5.55 in pre-market trading after declining 4.58% on Friday.
  • Monster Beverage Corporation MNST shares rose 5.2% to $64.50 in pre-market trading.
  • Uxin Limited UXIN rose 5% to $2.12 in pre-market trading after gaining 4.12% on Friday.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • VBI Vaccines Inc VBIV shares fell 31.2% to $1.30 in pre-market trading after the company reported results from its Phase 3 Study of Sci-b-vac. The trial met both co-primary endpoints but did not meet its secondary objective of non-inferiority.
  • Ampio Pharmaceuticals Inc AMPE fell 21.4% to $0.55 in pre-market trading after reporting a common stock offering.
  • Celyad SA CYAD fell 20.3% to $14.75 in pre-market trading.
  • Bionano Genomics, Inc. BNGO fell 13.8% to $2.50 in pre-market trading.
  • Seanergy Maritime Holdings Corp. SHIP fell 9.2% to $0.59 in pre-market trading. Seanergy Maritime reported a Q4 loss of $3.23 per share, versus a year-ago loss of $1.40 per share. Its sales declined to $16.013 million from $21.322 million.
  • Genocea Biosciences, Inc. GNCA fell 6.8% to $4.91 in pre-market trading.
  • Bridgeline Digital, Inc. BLIN fell 6.2% to $2.58 in pre-market trading.
  • Seadrill Limited SDRL fell 4.2% to $2.99 in pre-market trading after dropping 9.30% on Friday.
  • ContraVir Pharmaceuticals, Inc. CTRV fell 3.5% to $8.58 in pre-market trading after declining 12.07% on Friday.
  • Endo International plc ENDP fell 3.5% to $3.91 in pre-market trading after dropping 9.40% on Friday.
  • NextEra Energy Partners, LP NEP fell 3.3% to $45.02 in pre-market trading.
  • India Globalization Capital, Inc. IGC fell 4% to $1.21 in pre-market trading following Q4 results.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!